Using antibodies for LRP1B intracellular domain, Asano et al. found not only a membrane and cytoplasmic LRP1B expression pattern in the majority of the invasive ductal breast carcinoma patient samples analyzed, but also nuclear expression in a lower number of cases. The gene discussed is LRP1B; the disease is invasive ductal breast carcinoma.